{"schema":"OTR-CURRENT-SIGNAL-READER-1","presentationSchema":"OTR-SIGNAL-SLIDES-1","signalId":"SIG-8994ac8313bfd01597197a85-04","canonicalUrl":"https://ontherice.org/signals/SIG-8994ac8313bfd01597197a85-04/","title":"THERMO FISHER SCIENTIFIC (NYSE: TMO)","category":"Investment","representation":"current-guided-reader","originalResearch":"preserved-separately","sources":[{"title":"Reference source","url":"https://stockanalysis.com/stocks/tmo/","contexts":["Original research record","Call and evidence","What changed","Evidence, memory & review 4 linked sources"]},{"title":"ir.thermofisher.com ↗","url":"https://ir.thermofisher.com/investors/news-events/news/news-details/2026/Thermo-Fisher-Scientific-Reports-Third-Quarter-2026-Results/default.aspx","contexts":["Original research record","What changed","Evidence, memory & review 4 linked sources"]},{"title":"stockanalysis.com ↗","url":"https://stockanalysis.com/stocks/tmo/transcripts/713944-q3-2026/","contexts":["Original research record","What changed","Evidence, memory & review 4 linked sources"]},{"title":"investors.danaher.com ↗","url":"https://investors.danaher.com/2026-10-21-Danaher-Reports-Third-Quarter-2026-Results","contexts":["Original research record","What changed","Evidence, memory & review 4 linked sources"]}],"chapters":[{"id":"otr-slide-SIG-8994ac8313bfd01597197a85-04-detail-1","url":"https://ontherice.org/signals/SIG-8994ac8313bfd01597197a85-04/#otr-slide-SIG-8994ac8313bfd01597197a85-04-detail-1","title":"OTR EMERGING DATA","topic":"emerging","kind":"cover","text":"Start with the main idea: what may be changing, how the clues connect, and what remains uncertain. The key test is whether profit improvement survives removal of a one-off tariff benefit. Subtracting that benefit still leaves roughly 70 hundredths of a percentage point of margin improvement. Fresh growth excluding the effects the company specifies, such as currency changes and acquisitions, cash generation and a separate Danaher release point toward improving laboratory demand, rather than only accounting support. The inference is a modest continued recovery, not a forecast that all end markets have recovered.","links":[]},{"id":"otr-slide-SIG-8994ac8313bfd01597197a85-04-detail-3","url":"https://ontherice.org/signals/SIG-8994ac8313bfd01597197a85-04/#otr-slide-SIG-8994ac8313bfd01597197a85-04-detail-3","title":"The idea, step by step","topic":"emerging","kind":"research","text":"Start with the main idea: what may be changing, how the clues connect, and what remains uncertain. Read the matching explanation in OTR EMERGING DATA .","links":["https://ontherice.org/signals/SIG-8994ac8313bfd01597197a85-04/#otr-slide-SIG-8994ac8313bfd01597197a85-04-detail-1"]},{"id":"otr-slide-SIG-8994ac8313bfd01597197a85-04-detail-4","url":"https://ontherice.org/signals/SIG-8994ac8313bfd01597197a85-04/#otr-slide-SIG-8994ac8313bfd01597197a85-04-detail-4","title":"The key clues","topic":"emerging","kind":"research","text":"See the main observations behind the idea, with their important qualifications. The official TMO release confirms 9% reported revenue growth, 6% growth excluding the effects the company specifies, such as currency changes and acquisitions and a 24.5% share of revenue left as profit from running the business before interest and tax, after the company’s adjustments versus 23.3%. Cash from operations after spending on long-lived assets rose from $1.840 billion to $2.115 billion, about 14.9% by arithmetic. The transcript supports the tariff contribution and guidance bridge; the 70-basis-point residual is an arithmetic adjustment, not a complete management-reconciled underlying-margin measure.","links":[]},{"id":"otr-slide-SIG-8994ac8313bfd01597197a85-04-detail-5","url":"https://ontherice.org/signals/SIG-8994ac8313bfd01597197a85-04/#otr-slide-SIG-8994ac8313bfd01597197a85-04-detail-5","title":"What could change this view?","topic":"changes","kind":"research","text":"See what could change this interpretation and what still needs to be checked. Q4 growth forecast excluding the effects the company specifies, such as currency changes and acquisitions remains 4%, academic demand was flat, and $0.15 of the quarterly $0.26 profit per share beat came from the tariff refund. Seven observations, four unique links and three originators; five observations are tied to TMO’s earnings disclosure.","links":[]},{"id":"otr-slide-SIG-8994ac8313bfd01597197a85-04-detail-6","url":"https://ontherice.org/signals/SIG-8994ac8313bfd01597197a85-04/#otr-slide-SIG-8994ac8313bfd01597197a85-04-detail-6","title":"What this means","topic":"emerging","kind":"research","text":"Read the takeaway and the limits that matter before drawing a conclusion. Part of the margin improvement survives the simple tariff subtraction, but the saved one-week price outcome remains uncertain. Its source facts and prices still need independent checks.","links":[]},{"id":"otr-slide-SIG-8994ac8313bfd01597197a85-04-detail-7","url":"https://ontherice.org/signals/SIG-8994ac8313bfd01597197a85-04/#otr-slide-SIG-8994ac8313bfd01597197a85-04-detail-7","title":"Evidence behind this view","topic":"evidence","kind":"research","text":"Review the information supporting this view and the limits on what it can show. Checks whether separate pieces of evidence support the same view. Evidence 1 — Thermo Fisher reported 6% revenue growth excluding the effects the company specifies, such as currency changes and acquisitions, within 9% reported growth. Evidence 2 — share of revenue left as profit from running the business before interest and tax, after the company’s adjustments rose from 23.3% to 24.5%. Removing approximately 50 hundredths of a percentage point from a tariff refund leaves about 70 hundredths of a percentage point of underlying expansion, a calculation. Evidence 3 — Quarterly cash from operations after spending on long-lived assets rose from $1.840bn to $2.115bn, approximately 14.9% growth. Evidence 4 — Laboratory Products and Biopharma Services delivered 10% growth excluding the effects the company specifies, such as currency changes and acquisitions, with segment margin rising from 14.5% to 15.5%. Evidence 5 — Full-year adjusted profit per share guidance rose to $25.13–25.43. The $0.15 midpoint increase included $0.09 from operations, $0.05 from tariffs and $0.01 from FX. Evidence 6 — Separately, Danaher reported 5.5% core growth excluding respiratory testing and raised profit per share guidance. This supports the sector-demand inference, not a claim about TMO’s orders. That is evidence of price acceptance, not proof of future gains. Source clocks TMO release: 21 October, 18:01 SGT; its call began 19:00 SGT. Danaher release: 21 October, 18:00 SGT. Market observations: 21 October, 21:30 SGT opening; 22 October, 04:00 SGT close and 07:56 SGT after-hours.","links":[]},{"id":"otr-slide-SIG-8994ac8313bfd01597197a85-04-detail-9","url":"https://ontherice.org/signals/SIG-8994ac8313bfd01597197a85-04/#otr-slide-SIG-8994ac8313bfd01597197a85-04-detail-9","title":"Evidence against this view","topic":"changes","kind":"research","text":"Check the opposing evidence and other explanations that could weaken this view. Shows evidence and risks that could challenge this view. Q4 organic guidance is 4%, below Q3’s 6%; academic demand was flat. The tariff refund explained $0.15 of the $0.26 quarterly profit per share beat. Customer timing also limits a straight-line growth interpretation. Danaher’s ex-respiratory comparison is sector support, not proof of TMO orders.","links":[]},{"id":"otr-slide-SIG-8994ac8313bfd01597197a85-04-detail-11","url":"https://ontherice.org/signals/SIG-8994ac8313bfd01597197a85-04/#otr-slide-SIG-8994ac8313bfd01597197a85-04-detail-11","title":"What people say vs the facts","topic":"evidence","kind":"research","text":"Compare what people say with the observations, without treating attention as proof. Compares recorded public discussion with checked market facts. Research gap: No independent, source-matched sentiment or positioning series was established for this original issue window. Corporate disclosures and a price observation are not a measured crowd-positioning signal.","links":[]},{"id":"otr-slide-SIG-8994ac8313bfd01597197a85-04-detail-13","url":"https://ontherice.org/signals/SIG-8994ac8313bfd01597197a85-04/#otr-slide-SIG-8994ac8313bfd01597197a85-04-detail-13","title":"Signal category","topic":"evidence","kind":"research","text":"Read the details behind this part of the research and how they connect to the main idea. Investments","links":[]},{"id":"otr-slide-SIG-8994ac8313bfd01597197a85-04-detail-14","url":"https://ontherice.org/signals/SIG-8994ac8313bfd01597197a85-04/#otr-slide-SIG-8994ac8313bfd01597197a85-04-detail-14","title":"Company or instrument","topic":"evidence","kind":"research","text":"Read the details behind this part of the research and how they connect to the main idea. {\"currency\":\"USD\",\"name\":\"Thermo Fisher Scientific\",\"symbol\":\"TMO\",\"venue\":\"NYSE\"}","links":[]},{"id":"otr-slide-SIG-8994ac8313bfd01597197a85-04-detail-15","url":"https://ontherice.org/signals/SIG-8994ac8313bfd01597197a85-04/#otr-slide-SIG-8994ac8313bfd01597197a85-04-detail-15","title":"Summary","topic":"evidence","kind":"research","text":"Read the details behind this part of the research and how they connect to the main idea. Read the matching explanation in OTR EMERGING DATA .","links":["https://ontherice.org/signals/SIG-8994ac8313bfd01597197a85-04/#otr-slide-SIG-8994ac8313bfd01597197a85-04-detail-1"]},{"id":"otr-slide-SIG-8994ac8313bfd01597197a85-04-detail-16","url":"https://ontherice.org/signals/SIG-8994ac8313bfd01597197a85-04/#otr-slide-SIG-8994ac8313bfd01597197a85-04-detail-16","title":"opposing explanations","topic":"evidence","kind":"research","text":"Check the opposing evidence and other explanations that could weaken this view. Read the matching explanation in Chapter 5 .","links":["https://ontherice.org/signals/SIG-8994ac8313bfd01597197a85-04/#otr-slide-SIG-8994ac8313bfd01597197a85-04-detail-5"]},{"id":"otr-slide-SIG-8994ac8313bfd01597197a85-04-detail-17","url":"https://ontherice.org/signals/SIG-8994ac8313bfd01597197a85-04/#otr-slide-SIG-8994ac8313bfd01597197a85-04-detail-17","title":"What changed","topic":"evidence","kind":"research","text":"See what changed in the research and why, while keeping earlier recorded views separate. Recorded public history Subtracting that benefit still leaves roughly 70… This is the first recorded public view. Further public updates will appear here. The key test is whether profit improvement survives removal of a one-off tariff benefit. Subtracting that benefit still leaves roughly 70 hundredths of a percentage point of margin improvement. Forecast prepared: 22 Oct, 10:02 SGT Published by OTR: 22 Oct 2026, 11:16 SGT","links":[]},{"id":"otr-slide-SIG-8994ac8313bfd01597197a85-04-detail-18","url":"https://ontherice.org/signals/SIG-8994ac8313bfd01597197a85-04/#otr-slide-SIG-8994ac8313bfd01597197a85-04-detail-18","title":"Evidence, memory & review 4 linked sources","topic":"sources","kind":"research","text":"Check where the information came from, when it was observed and what was verified. Named assets or actors: Thermo Fisher Scientific (TMO) Source trail Any forecast estimate is shown separately with its own source and limitations.","links":[]},{"id":"otr-slide-SIG-8994ac8313bfd01597197a85-04-detail-20","url":"https://ontherice.org/signals/SIG-8994ac8313bfd01597197a85-04/#otr-slide-SIG-8994ac8313bfd01597197a85-04-detail-20","title":"OTR reasoning · Why we see this connection","topic":"evidence","kind":"research","text":"Follow the reasoning from the observations to the proposed result. A possible link is not proof. OTR’s interpretation: First, compare the reported margin improvement with the disclosed tariff contribution. Subtracting roughly 50 hundredths of a percentage point from the 120-basis-point improvement leaves a 70-basis-point arithmetic residual. Second, compare that with growth excluding the effects the company specifies, such as currency changes and acquisitions and cash generation. Third, Danaher provides separate sector context, while neither company proves a one-week TMO price outcome.","links":[]},{"id":"otr-slide-SIG-8994ac8313bfd01597197a85-04-detail-21","url":"https://ontherice.org/signals/SIG-8994ac8313bfd01597197a85-04/#otr-slide-SIG-8994ac8313bfd01597197a85-04-detail-21","title":"Counterpoint · Another possible explanation","topic":"evidence","kind":"research","text":"Check the opposing evidence and other explanations that could weaken this view. Read the matching explanation in Chapter 5 .","links":["https://ontherice.org/signals/SIG-8994ac8313bfd01597197a85-04/#otr-slide-SIG-8994ac8313bfd01597197a85-04-detail-5"]},{"id":"otr-slide-SIG-8994ac8313bfd01597197a85-04-detail-22","url":"https://ontherice.org/signals/SIG-8994ac8313bfd01597197a85-04/#otr-slide-SIG-8994ac8313bfd01597197a85-04-detail-22","title":"Review status","topic":"evidence","kind":"research","text":"Check what was reviewed, what remains uncertain and how much the sources can support. LEARNING REVIEWED WITH DISCLOSED LIMITS","links":[]},{"id":"otr-slide-SIG-8994ac8313bfd01597197a85-04-detail-23","url":"https://ontherice.org/signals/SIG-8994ac8313bfd01597197a85-04/#otr-slide-SIG-8994ac8313bfd01597197a85-04-detail-23","title":"Keep exploring","topic":"connections","kind":"finish","text":"Choose how to follow this Signal or compare it with other research. Track this Signal to find it again, compare the evidence, and revisit its recorded outcome. Explore more Signals →","links":["https://ontherice.org/signals/"]},{"id":"otr-slide-SIG-8994ac8313bfd01597197a85-04-detail-24","url":"https://ontherice.org/signals/SIG-8994ac8313bfd01597197a85-04/#otr-slide-SIG-8994ac8313bfd01597197a85-04-detail-24","title":"Terms in simple English","topic":"glossary","kind":"glossary","text":"Find plain meanings for the specialist terms used in this research. Asset or investible Something that can be bought or sold, such as a share, bond, fund, currency or cryptocurrency. Entry or reference price A reference quote is not proof that a trade could be made at that price. Horizon or deadline The forecast time window. A saved deadline states when the outcome should be checked. HIT and MISS MISS means it did not meet those rules. These labels do not measure profit after trading costs. Estimates whose accuracy has not been established by testing A judgement that has not been shown to match real outcomes reliably. It is not a proven success rate. Revenue Money earned from sales before subtracting costs. Earnings or net income A company’s profit after its costs. Earnings reports show how much it made or lost. Profit per share (profit per share) Company profit divided by its number of shares. It helps compare profit with the share price. Margin Profit compared with sales after the stated costs. A lower share of sales kept as profit means less profit from each dollar of sales. Margin in context A business margin compares revenue with stated costs; it may be a percentage or profit per unit, such as dollars per barrel. For a leveraged trade, margin means money required to support the position. Check the stated measure. Share of revenue left as profit from running the business before interest and tax The share of sales left after normal running costs, before interest and tax. Cash flow Money moving into and out of a business. A reported profit does not always mean cash has arrived. Cash from operations after spending on long-lived assets Cash left after business running costs and spending on long-lasting assets. Guidance or outlook Management’s forecast for future sales, profit or other results. It can change. Hundredth of a percentage point (bp or bps) One hundredth of a percentage point is 0.01 percentage point. A move of 25 hundredths of a percentage point equals 0.25 percentage point. Foreign exchange (FX) The currency market. EUR/USD shows US dollars per euro; a rising pair means the first currency strengthens against the second. Ticker The short code identifying an asset on a venue. Venue, currency and exact instrument still matter. Exchange or venue The market or trading platform supplying a quote. NASDAQ and NYSE are US exchanges; SGX is Singapore Exchange. Prices can differ by venue. Organic or constant-currency growth Organic growth excludes stated changes from buying or selling businesses. Constant-currency growth removes exchange-rate effects under the stated method. Quarter (Q1 to Q4) A three-month reporting period. Company financial years can start in different months. Tariff A tax on goods crossing a border. It can change costs, demand and profits. Where the information came from Where information came from and how it was collected or changed. UTC and SGT UTC is a world time standard. SGT is Singapore time, eight hours ahead of UTC.","links":[]}]}